Institutional investors control 17.51% of the outstanding shares in AZN. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended June 2019, these large investors purchased a net $16.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
IRISH LIFE INVESTMENT MANAGERS L... Bought 129.1 Thousand shares of AstraZeneca PLC
DOMINI IMPACT INVESTMENTS LLC Bought 96.9 Thousand shares of AstraZeneca PLC
HARVEST PORTFOLIOS GROUP, INC. Bought 32.9 Thousand shares of AstraZeneca PLC